Efficacy of Dr. SKS Hair Booster Serum for the Treatment of Hair Loss in COVID-19 Induced Persistent Telogen Effluvium

The study "Efficacy of Dr. SKS hair booster serum for the treatment of hair loss in COVID-19 induced persistent telogen effluvium" involved 500 patients aged 18 to 60 years who had recovered from COVID-19 but were experiencing sustained hair fall even after 6 months. The patients were treated with 1 millilitre of Dr. SKS hair booster serum injection administered intradermally in the scalp. The results showed that approximately half of the patients demonstrated excellent improvement in expert panel global photographic assessment at 3 months (vertex area; 43.6% and frontal area; 46%) that increased at 6 months (vertex area; 48% and frontal area; 50%). All patients' clinical conditions improved and they were satisfied with the results in terms of mean total hair growth satisfaction scale score of five aspects at 3 and 6 months treatment. The study concluded that intradermal injection of Dr. SKS hair booster serum is an effective treatment for hair loss in COVID-19-induced persistent telogen effluvium.